Cryptotanshinone enhances wound healing in type 2 diabetes with modulatory effects on inflammation, angiogenesis and extracellular matrix remodelling. (1st January 2020)
- Record Type:
- Journal Article
- Title:
- Cryptotanshinone enhances wound healing in type 2 diabetes with modulatory effects on inflammation, angiogenesis and extracellular matrix remodelling. (1st January 2020)
- Main Title:
- Cryptotanshinone enhances wound healing in type 2 diabetes with modulatory effects on inflammation, angiogenesis and extracellular matrix remodelling
- Authors:
- Song, Min
Chen, Lu
Zhang, Lusha
Li, Chunxiao
Coffie, Joel Wake
Fang, Zhirui
Zhang, Liyuan
Wang, Shaoxia
Gao, Xiumei
Wang, Hong - Abstract:
- Abstract: Context: Cryptotanshinone (CT) is a diterpene quinone compound from Salvia miltiorrhiza Bge. Labiatae has been widely used in cardio-cerebral vascular diseases, which could be potentially effective in treating diabetic wounds. Objective: This study evaluates the wound healing activity of CT by employing an excisional wound splinting model in db/db mice. Materials and methods: Wounds were induced at the dorsum of non-diabetic (db/+) and diabetic (db/db) mice and treated with sodium carboxymethyl cellulose (CMC-Na) or 300 mg/kg/d CT for 16 days. Wound closure was measured every two days. Body weight, fasting blood glucose, re-epithelialization, granulation, leukocyte infiltration, capillary density, collagen deposition and expressions of CXCL1, CXCL2, VEGF, Ang-1, p-eNOS, eNOS, α-SMA, MMP2 and MMP9 were analysed. Expression of VEGF and tube formation was measured in vitro with human umbilical vein endothelial cells (HUVECs). Results: CT significantly accelerated rate of wound closure, as the contraction ratio increased from 68% (non-treated group) to 83% (CT-treated group) at days 16 post-injury. A significant increase was observed in re-epithelialization and granulation tissue formation. Mechanistically, CT suppressed leukocyte infiltration and CXCL1 and CXCL2 expression. CT treatment also increased blood vessel density and expression level of VEGF, Ang-1 and p-eNOS. In vitro, CT boosted expression of VEGF and tube formation of endothelial cells. Moreover,Abstract: Context: Cryptotanshinone (CT) is a diterpene quinone compound from Salvia miltiorrhiza Bge. Labiatae has been widely used in cardio-cerebral vascular diseases, which could be potentially effective in treating diabetic wounds. Objective: This study evaluates the wound healing activity of CT by employing an excisional wound splinting model in db/db mice. Materials and methods: Wounds were induced at the dorsum of non-diabetic (db/+) and diabetic (db/db) mice and treated with sodium carboxymethyl cellulose (CMC-Na) or 300 mg/kg/d CT for 16 days. Wound closure was measured every two days. Body weight, fasting blood glucose, re-epithelialization, granulation, leukocyte infiltration, capillary density, collagen deposition and expressions of CXCL1, CXCL2, VEGF, Ang-1, p-eNOS, eNOS, α-SMA, MMP2 and MMP9 were analysed. Expression of VEGF and tube formation was measured in vitro with human umbilical vein endothelial cells (HUVECs). Results: CT significantly accelerated rate of wound closure, as the contraction ratio increased from 68% (non-treated group) to 83% (CT-treated group) at days 16 post-injury. A significant increase was observed in re-epithelialization and granulation tissue formation. Mechanistically, CT suppressed leukocyte infiltration and CXCL1 and CXCL2 expression. CT treatment also increased blood vessel density and expression level of VEGF, Ang-1 and p-eNOS. In vitro, CT boosted expression of VEGF and tube formation of endothelial cells. Moreover, extracellular matrix (ECM) remodelling was enhanced by CT via promoting fibroblast transformation and inhibiting MMP2 and MMP9. Conclusions: Our study provides evidence that CT could be developed as a potential therapeutic agent for the treatment of chronic diabetic wound healing. … (more)
- Is Part Of:
- Pharmaceutical biology. Volume 58:Number 1(2020)
- Journal:
- Pharmaceutical biology
- Issue:
- Volume 58:Number 1(2020)
- Issue Display:
- Volume 58, Issue 1 (2020)
- Year:
- 2020
- Volume:
- 58
- Issue:
- 1
- Issue Sort Value:
- 2020-0058-0001-0000
- Page Start:
- 845
- Page End:
- 853
- Publication Date:
- 2020-01-01
- Subjects:
- Diabetic wounds -- re-epithelialization -- CXCL1 -- CXCL2 -- VEGF -- fibroblast transformation
Pharmacognosy -- Periodicals
Materia medica, Vegetable -- Periodicals
615.321 - Journal URLs:
- http://www.tandfonline.com/toc/iphb20/current ↗
http://informahealthcare.com/journal/phb ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/13880209.2020.1803369 ↗
- Languages:
- English
- ISSNs:
- 1388-0209
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6442.767000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 22163.xml